EUVIMED · CrossrefJournal
npj Gut and Liver
ISSN 3004-9806 · Springer Science and Business Media LLC
Latest articles
Bile acid dysmetabolism and microbial dysbiosis coincide with Clostridioides difficile infection in pediatric inflammatory bowel disease
Evaluation of an audio-based monitoring system for detecting retching and vomiting in gastroparesis: an observational cohort study
Hepatic GPR110 plays a complex and context-dependent role in metabolic dysfunction-associated steatotic liver disease
Single-cell insights into hepatic fibroblasts and stellate cells: heterogeneity in matrix remodelling in development, health, and disease
Generation MASLD: a precision medicine framework for young-onset metabolic dysfunction-associated steatotic liver disease
The pathway network of aldo-keto reductase 1b10: a new perspective on gene-targeted therapy
A therapeutic turning point in metabolic liver disease
Small intestinal bacterial overgrowth is common in celiac disease but is not associated with Marsh score
Prebiotic xylo-oligosaccharides for alleviation of hepatic steatosis: results from a four-month dietary intervention and determinants of response
Immune-cell-specific genetic drivers of cholelithiasis revealed by single-cell transcriptome-wide Mendelian randomization and colocalization
Leveraging artificial intelligence in eosinophilic esophagitis
Endocrine disruptors reprogram hepatic metabolic and immune gene networks to promote hepatocellular carcinoma
Drug-induced inflammatory colitis: a review of novel agents
Human colonic organoid monolayers reveal biological sex and psychological state influence epithelial responses to Campylobacter jejuni infection
Trajectory of compensated metabolic dysfunction-associated steatohepatitis in a tertiary center with a large hispanic/latino population
PARPs in liver diseases
Silencing of S100A11 attenuates murine metabolic dysfunction-associated steatohepatitis
Adrenergic G protein-coupled receptors in liver physiology and pathology: research advances and clinical implications
Decoding the molecular and genomic landscape of hepatocellular carcinoma: biomarker discovery, classification frameworks, and therapeutic targeting
Pathophysiology, noninvasive diagnostics and emerging personalized treatments for metabolic associated liver diseases
Improving immunotherapy for the treatment of hepatocellular carcinoma: learning from patients and preclinical models
Pharmaceutical and clinical implications of proton pump inhibitors with dual antiplatelet therapies: a systematic review
Gut microbiota and dynamics of ammonia metabolism in liver disease
Optimizing the liver transplant candidate
Alterations of the peptidomic composition of peripheral plasma after portal hypertension correction by transjugular intrahepatic portosystemic shunt
Accelerometer-based sedentary time and physical activity with MASLD and liver cirrhosis in 2684 British adolescents
Resmetirom and GLP-1 agonists for MASH: complementary rather than exclusive
Patients with ulcerative colitis who have normalized histology are clinically stable after de-escalation of therapy
The Microleaks study: 16S community profile and metagenomic shotgun sequencing signatures associated with anastomotic leak
Stiffness-induced modulation of ERG transcription factor in chronic liver disease
EUVIMED